(Q49030310)

17 February 2018

title

Imbalance of brain monoamines and clinical disorders. (English)

1 reference

17 February 2018

author name string

Hornykiewicz O

series ordinal

1

1 reference

17 February 2018

publication date

1 January 1982

1 reference

17 February 2018

Progress in Brain Research

published in

1 reference

17 February 2018

volume

55

1 reference

17 February 2018

page(s)

419-429

1 reference

17 February 2018

Development of β-adrenergic receptor subsensitivity by antidepressants

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

Decreased homovanillic acid concentration in the brain in parkinsonian subjects as an expression of a disorder of central dopamine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

[Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

Bromocriptine in Parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

Neuroendocrine and amine studies in affective illness

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

Tryptophan-nicotinamide, imipramine and their combination in depression. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

The Comparative Antidepressant Value of L-Tryptophan and Imipramine With and Without Attempted Potentiation by Liothyronine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

Rotational behaviour produced in rats by unilateral electrolytic lesions of the ascending noradrenergic bundles

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

The physiology and pharmacology of mammalian basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

Cholinergic-anticholinergic antagonism in parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

The effects of chronic treatment with the 5-hydroxytryptamine uptake blocker zimelidine on central 5-hydroxytryptamine mechanisms. Evidence for the induction of a low affinity binding site for 5-hydroxytryptamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

Evidence for existence of two opposite noradrenergic brain systems controlling behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

Receptor basis for dopaminergic supersensitivity in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

L-Glutamic Acid Decarboxylase in Parkinson's Disease: Effect of L-Dopa Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

Distribution of choline acetyltransferase and glutamate decarboxylase within the substantia nigra and in other brain regions from control and Parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

Noradrenergic Function and Depression, Too Much or Too Little?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

Catecholamine Metabolism, Depressive Illness, and Drug Response

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

Effects of chronic desipramine treatment on rat brain noradrenergic responses to α-adrenergic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

5-hydroxytryptamine, noradrenaline, and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

MHPG excretion in depressive disorders: relation to clinical subtypes and desynchronized sleep

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

5-Hydroxytryptamine in the Hind-Brain of Depressive Suicides

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

Mode of action of antidepressant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

Comparative trial of L-tryptophan and amitriptyline in depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964212-0

7 January 2021

10.1016/S0079-6123(08)64212-0

Identifiers

DOI

0 references

1 reference

17 February 2018